comparemela.com

Salarius Pharmaceuticals, Inc. (SLRX) Announces Interim Results from Phase 1/2 Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas

Salarius Pharmaceuticals, Inc. (SLRX) Announces Interim Results from Phase 1/2 Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

New York ,United States ,Memorial Sloan Kettering Cancer Center ,Fox Chase Cancer Center ,Pennsylvania ,Dana Farber Cancer Institute ,Massachusetts ,Philadelphia ,Santa Monica ,Texas ,Petersburg ,Sankt Peterburg ,Russia ,Boston ,Virginia ,Houston ,American ,Los Angeles ,David Arthur ,Damon Reed ,Oregon Health Sciences University Portland ,Young Adult Program ,University Of Washington Medical Center ,Md Anderson Cancer Center ,Nasdaq ,American Society Of Hematology ,Washington University ,Salarius Pharmaceuticals Inc ,Seattle Cancer Care Alliance ,Fred Hutchinson Cancer Research Center ,Drug Administration ,Moffitt Cancer Center ,Sarcoma Oncology Center ,Euro Ewing Consortium ,Program Leader ,Wall Street ,Adolescent Young Adult Program ,American Society ,Cancer Center ,Seattle Children ,Washington Medical Center ,Oregon Health ,Sciences University Portland ,Johns Hopkins All Children ,Nationwide Children ,Virginia Cancer Specialists ,Cleveland Clinic ,Salarius Sarcoma ,

comparemela.com © 2020. All Rights Reserved.